ID   AADAT_MOUSE             Reviewed;         425 AA.
AC   Q9WVM8;
DT   13-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   04-FEB-2015, entry version 101.
DE   RecName: Full=Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial;
DE            Short=KAT/AadAT;
DE   AltName: Full=2-aminoadipate aminotransferase;
DE   AltName: Full=2-aminoadipate transaminase;
DE            EC=2.6.1.39;
DE   AltName: Full=Alpha-aminoadipate aminotransferase;
DE            Short=AadAT;
DE   AltName: Full=Kynurenine aminotransferase II;
DE   AltName: Full=Kynurenine--oxoglutarate aminotransferase II;
DE   AltName: Full=Kynurenine--oxoglutarate transaminase 2;
DE            EC=2.6.1.7;
DE   AltName: Full=Kynurenine--oxoglutarate transaminase II;
DE   Flags: Precursor;
GN   Name=Aadat; Synonyms=Kat2;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   STRAIN=129/SvJ;
RX   PubMed=10441733; DOI=10.1007/s003359901102;
RA   Yu P., Mosbrook D.M., Tagle D.A.;
RT   "Genomic organization and expression analysis of mouse kynurenine
RT   aminotransferase II, a possible factor in the pathophysiology of
RT   Huntington's disease.";
RL   Mamm. Genome 10:845-852(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Kidney;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   SUCCINYLATION [LARGE SCALE ANALYSIS] AT LYS-172; LYS-263; LYS-339 AND
RP   LYS-367, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=23806337; DOI=10.1016/j.molcel.2013.06.001;
RA   Park J., Chen Y., Tishkoff D.X., Peng C., Tan M., Dai L., Xie Z.,
RA   Zhang Y., Zwaans B.M., Skinner M.E., Lombard D.B., Zhao Y.;
RT   "SIRT5-mediated lysine desuccinylation impacts diverse metabolic
RT   pathways.";
RL   Mol. Cell 50:919-930(2013).
RN   [5]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-69; LYS-179; LYS-263;
RP   LYS-339; LYS-351; LYS-367 AND LYS-422, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=23576753; DOI=10.1073/pnas.1302961110;
RA   Rardin M.J., Newman J.C., Held J.M., Cusack M.P., Sorensen D.J.,
RA   Li B., Schilling B., Mooney S.D., Kahn C.R., Verdin E., Gibson B.W.;
RT   "Label-free quantitative proteomics of the lysine acetylome in
RT   mitochondria identifies substrates of SIRT3 in metabolic pathways.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:6601-6606(2013).
CC   -!- FUNCTION: Transaminase with broad substrate specificity. Has
CC       transaminase activity towards aminoadipate, kynurenine, methionine
CC       and glutamate. Shows activity also towards tryptophan, aspartate
CC       and hydroxykynurenine. Accepts a variety of oxo-acids as amino-
CC       group acceptors, with a preference for 2-oxoglutarate, 2-
CC       oxocaproic acid, phenylpyruvate and alpha-oxo-gamma-methiol
CC       butyric acid. Can also use glyoxylate as amino-group acceptor (in
CC       vitro) (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: L-kynurenine + 2-oxoglutarate = 4-(2-
CC       aminophenyl)-2,4-dioxobutanoate + L-glutamate.
CC   -!- CATALYTIC ACTIVITY: L-2-aminoadipate + 2-oxoglutarate = 2-
CC       oxoadipate + L-glutamate.
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC   -!- PATHWAY: Amino-acid degradation; L-lysine degradation via
CC       saccharopine pathway; glutaryl-CoA from L-lysine: step 4/6.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed mainly in kidney and to a lesser
CC       amount in liver and brain. {ECO:0000269|PubMed:10441733}.
CC   -!- SIMILARITY: Belongs to the class-I pyridoxal-phosphate-dependent
CC       aminotransferase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF072376; AAD39680.1; -; mRNA.
DR   EMBL; AK075578; BAC35833.1; -; mRNA.
DR   EMBL; BC012637; AAH12637.1; -; mRNA.
DR   CCDS; CCDS22320.1; -.
DR   RefSeq; NP_035964.1; NM_011834.2.
DR   UniGene; Mm.35020; -.
DR   ProteinModelPortal; Q9WVM8; -.
DR   SMR; Q9WVM8; 1-425.
DR   IntAct; Q9WVM8; 2.
DR   MINT; MINT-1860782; -.
DR   PhosphoSite; Q9WVM8; -.
DR   MaxQB; Q9WVM8; -.
DR   PaxDb; Q9WVM8; -.
DR   PRIDE; Q9WVM8; -.
DR   Ensembl; ENSMUST00000079472; ENSMUSP00000078436; ENSMUSG00000057228.
DR   GeneID; 23923; -.
DR   KEGG; mmu:23923; -.
DR   UCSC; uc009lte.1; mouse.
DR   CTD; 51166; -.
DR   MGI; MGI:1345167; Aadat.
DR   eggNOG; COG1167; -.
DR   GeneTree; ENSGT00390000004594; -.
DR   HOGENOM; HOG000223057; -.
DR   HOVERGEN; HBG050429; -.
DR   InParanoid; Q9WVM8; -.
DR   KO; K00825; -.
DR   OMA; EWKLDND; -.
DR   OrthoDB; EOG7ZKSBF; -.
DR   PhylomeDB; Q9WVM8; -.
DR   TreeFam; TF328598; -.
DR   Reactome; REACT_239844; Lysine catabolism.
DR   Reactome; REACT_240936; Tryptophan catabolism.
DR   UniPathway; UPA00868; UER00838.
DR   ChiTaRS; Aadat; mouse.
DR   NextBio; 303709; -.
DR   PRO; PR:Q9WVM8; -.
DR   Proteomes; UP000000589; Chromosome 8.
DR   Bgee; Q9WVM8; -.
DR   CleanEx; MM_AADAT; -.
DR   Genevestigator; Q9WVM8; -.
DR   GO; GO:0005739; C:mitochondrion; IDA:MGI.
DR   GO; GO:0047536; F:2-aminoadipate transaminase activity; ISS:UniProtKB.
DR   GO; GO:0016212; F:kynurenine-oxoglutarate transaminase activity; ISS:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:MGI.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro.
DR   GO; GO:0006103; P:2-oxoglutarate metabolic process; ISS:UniProtKB.
DR   GO; GO:0009058; P:biosynthetic process; IEA:InterPro.
DR   GO; GO:0006536; P:glutamate metabolic process; ISS:UniProtKB.
DR   GO; GO:0070189; P:kynurenine metabolic process; ISS:UniProtKB.
DR   GO; GO:0097052; P:L-kynurenine metabolic process; ISO:MGI.
DR   GO; GO:0033512; P:L-lysine catabolic process to acetyl-CoA via saccharopine; IEA:UniProtKB-UniPathway.
DR   GO; GO:0019441; P:tryptophan catabolic process to kynurenine; IEA:Ensembl.
DR   Gene3D; 3.40.640.10; -; 1.
DR   Gene3D; 3.90.1150.10; -; 1.
DR   InterPro; IPR004839; Aminotransferase_I/II.
DR   InterPro; IPR015424; PyrdxlP-dep_Trfase.
DR   InterPro; IPR015421; PyrdxlP-dep_Trfase_major_sub1.
DR   InterPro; IPR015422; PyrdxlP-dep_Trfase_major_sub2.
DR   Pfam; PF00155; Aminotran_1_2; 1.
DR   SUPFAM; SSF53383; SSF53383; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Aminotransferase; Complete proteome; Mitochondrion;
KW   Pyridoxal phosphate; Reference proteome; Transferase; Transit peptide.
FT   TRANSIT       1     29       Mitochondrion. {ECO:0000255}.
FT   CHAIN        30    425       Kynurenine/alpha-aminoadipate
FT                                aminotransferase, mitochondrial.
FT                                /FTId=PRO_0000020603.
FT   BINDING      20     20       Substrate. {ECO:0000250}.
FT   BINDING      74     74       Substrate. {ECO:0000250}.
FT   BINDING     202    202       Substrate. {ECO:0000250}.
FT   BINDING     399    399       Substrate. {ECO:0000250}.
FT   MOD_RES      69     69       N6-acetyllysine.
FT                                {ECO:0000269|PubMed:23576753}.
FT   MOD_RES     172    172       N6-succinyllysine.
FT                                {ECO:0000269|PubMed:23806337}.
FT   MOD_RES     179    179       N6-acetyllysine.
FT                                {ECO:0000269|PubMed:23576753}.
FT   MOD_RES     263    263       N6-(pyridoxal phosphate)lysine;
FT                                alternate. {ECO:0000250}.
FT   MOD_RES     263    263       N6-acetyllysine; alternate.
FT                                {ECO:0000269|PubMed:23576753}.
FT   MOD_RES     263    263       N6-succinyllysine; alternate.
FT                                {ECO:0000269|PubMed:23806337}.
FT   MOD_RES     339    339       N6-acetyllysine; alternate.
FT                                {ECO:0000269|PubMed:23576753}.
FT   MOD_RES     339    339       N6-succinyllysine; alternate.
FT                                {ECO:0000269|PubMed:23806337}.
FT   MOD_RES     351    351       N6-acetyllysine.
FT                                {ECO:0000269|PubMed:23576753}.
FT   MOD_RES     367    367       N6-acetyllysine; alternate.
FT                                {ECO:0000269|PubMed:23576753}.
FT   MOD_RES     367    367       N6-succinyllysine; alternate.
FT                                {ECO:0000269|PubMed:23806337}.
FT   MOD_RES     422    422       N6-acetyllysine.
FT                                {ECO:0000269|PubMed:23576753}.
SQ   SEQUENCE   425 AA;  47598 MW;  E3A6711CFE96D77E CRC64;
     MNYSRFLTAT SLARKPSPIR TTADILSKAP KTLISLAPGS PNPSMFPFKS AAFTVENGST
     IRFEDDLIKR ALQYSPSYGI PELLSWLKQF QVKLHNPPTV NYPPNQGQMD LCITSGCQDG
     LCKAFEMLIN PGDTILVNEP LFPGTLYAMK PLGCNIINVP SDEHGIIPEG LKKILSQWKP
     EDSKDPTKKT PKFLYTVPNG NNPTGNSLTG DRKKEIYELA RKYDFLIIED DPYYFLQFSK
     PWEPTFLSMD VDGRVIRADT FSKTVSSGLR VGFMTGPKTL IQNIVLHTQV SSVHACTLSQ
     LMILQLLHQW GEEGFLAHID RTIDFYKNQR DSILAAADKW LRGLAEWHVP KAGMFLWIKV
     KGISDTKQLI EEKAIEREVL LVPGNGFFID GSAPTSFFRA SFSLATPAQM DTAFQRLAQL
     IKESL
//
